As of May 22
| +0.06 / +1.40%|
The 4 analysts offering 12-month price forecasts for Synergy Pharmaceuticals Inc have a median target of 7.25, with a high estimate of 11.00 and a low estimate of 5.75. The median estimate represents a +66.67% increase from the last price of 4.35.
The current consensus among 4 polled investment analysts is to Buy stock in Synergy Pharmaceuticals Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.